Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Shared roles of immune and stromal cells in the pathogenesis of human bronchiolitis obliterans syndrome
Patrick W. Mellors, Ana N. Lange, Bruno Casino Remondo, Maksim Shestov, Joseph D. Planer, Andrew R. Peterson, Yun Ying, Su Zhou, Jason D. Christie, Joshua M. Diamond, Edward Cantu, Maria C. Basil, Saar Gill
Patrick W. Mellors, Ana N. Lange, Bruno Casino Remondo, Maksim Shestov, Joseph D. Planer, Andrew R. Peterson, Yun Ying, Su Zhou, Jason D. Christie, Joshua M. Diamond, Edward Cantu, Maria C. Basil, Saar Gill
View: Text | PDF
Research Article Hematology Immunology Pulmonology

Shared roles of immune and stromal cells in the pathogenesis of human bronchiolitis obliterans syndrome

  • Text
  • PDF
Abstract

Bronchiolitis obliterans syndrome (BOS) is a progressive, fatal obstructive lung disease that occurs following lung transplant, where it is termed chronic lung allograft dysfunction BOS (CLAD-BOS), or as the primary manifestation of pulmonary chronic graft versus host disease (cGVHD-BOS) following allogeneic hematopoietic stem cell transplant. Disease pathogenesis is poorly understood; however, chronic alloreactivity is common to both conditions, suggesting a shared pathophysiology. We performed single-cell RNA-Seq (scRNA-Seq) on explanted human lungs from 4 patients with CLAD-BOS, 3 patients with cGVHD-BOS, and 3 deceased controls to identify cell types, genes, and pathways enriched in BOS to better understand disease mechanisms. In both forms of BOS, we found an expanded population of CD8+ tissue resident memory T cells (TRM), which was distinct to BOS compared with other chronic lung diseases. In addition, BOS samples expressed genes and pathways associated with macrophage chemotaxis and proliferation, including in nonimmune cell populations. We also identified dysfunctional stromal cells in BOS, characterized by pro- and antifibrotic gene programs. These data suggest substantial cellular and molecular overlap between CLAD- and cGVHD-BOS and, therefore, common pathways for possible therapeutic intervention.

Authors

Patrick W. Mellors, Ana N. Lange, Bruno Casino Remondo, Maksim Shestov, Joseph D. Planer, Andrew R. Peterson, Yun Ying, Su Zhou, Jason D. Christie, Joshua M. Diamond, Edward Cantu, Maria C. Basil, Saar Gill

×

Figure 7

Multiplex immunofluorescence (mIF) imaging confirms expansion of TRM in BOS lungs with heterogenous spatial distribution.

Options: View larger image (or click on image) Download as PowerPoint
Multiplex immunofluorescence (mIF) imaging confirms expansion of TRM in ...
(A and B) Quantification of CD8+CD103+ and CD8+CD103+GZMB+ cells by sample for BOS (n = 3) versus NC (n = 3). Cell segmentation and marker quantification were performed on the entire 9 × 9 mm section using Visiopharm Oncotopix Discovery software. To normalize for differences in tissue quantity per section, absolute cell counts were divided by tissue area (mm2) calculated in QuPath. CB, CLAD-BOS; GB, cGVHD-BOS. Statistical comparison of means was performed using the student’s 1-tailed unpaired t test. *P < 0.05. (C) mIF images at 20× power illustrating infiltration of a terminal bronchiole by CD8+CD103+ T cells in a patient with CLAD-BOS. (D) mIF images at 20× power for a different CLAD-BOS patient with advanced fibrosis illustrating. From left to right: tissue expression of CD8, CD103, GZMB, and TIGIT with and without DAPI nuclear staining; CD8; TIGIT; CD103; and granzyme b and CD103. (E and F) H&E sections annotated with locations of mIF images from C and D, respectively. (G) Fraction of CD8+CD103+ cells that are negative for TIGIT and granzyme B (DN), positive for both (DP), and expressing either marker alone in the same patient with CLAD-BOS from D. Scale bars: 100 μM (C), 50 μM (D), 1000 μM (E and F).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts